 |
 |

Improved Treatment of the Stevens-Johnson Syndrome
Janet A. Marvin, RN, MN;
David M. Heimbach, MD;
Loren H. Engrav, MD;
Timothy J. Harnar, MD
Arch Surg. 1984;119(5):601-605.
Abstract
 |  |
The Stevens-Johnson syndrome (SJS), a disease resulting in greater than 30% body surface area epidermal and mucosal desquamation, is reported to have a mortality of greater than 50%. Recommended treatment has included steroids, prophylactic antibiotics, nutritional support, and application of topical antibacterials. Since the lesions represent only epidermal loss without dermal necrosis, rapid reepithelialization should occur if the dermis is protected from desiccation with a biological dressing. Five nonburned patients with severe SJS were treated in the University of Washington burn center, Seattle, with urgent operative débridement of their wounds and application of porcine xenograft immediately after admission. Steroid administration was stopped. Antibiotics were used only for culture-proved infections. All patients completely reepithelialized within a mean of 18 days. There was one death, a 9-year-old boy who was completely reepithelialized when sudden fatal sepsis that originated from a ventriculovenous shunt placed when he was an infant developed. In this group of patients, rapid wound closure with xenograft and supportive care permitted rapid reepithelialization and decreased mortality and morbidity.
(Arch Surg 1984;119:601-605)
Author Affiliations
From the Department of Surgery (Drs Marvin, Heimbach, and Harnar) and Division of Plastic Surgery (Dr Engrav), University of Washington, Harborview Medical Center, Seattle.
Footnotes
Accepted for publication Jan 6, 1984.
Read before the 91st annual meeting of the Western Surgical Association, Monterey, Calif, Nov 16, 1983.
Reprint requests to Department of Surgery, ZA-16, Harborview Medical Center, 325 Ninth Ave, Seattle, WA 98104 (Dr Heimbach).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Case 34-2005 -- A 10-Year-Old Girl with a Bullous Skin Eruption and Acute Respiratory Failure.
Sheridan et al.
NEJM 2005;353:2057-2066.
FULL TEXT
Management of Acquired Bullous Skin Diseases
Fine
NEJM 1995;333:1475-1484.
FULL TEXT
A Comprehensive Approach: Multidisciplinary Management in a Burn Center
Taylor et al.
CLIN PEDIATR 1989;28:404-407.
ABSTRACT
Treatment of Toxic Epidermal Necrolysis: Creteil's Experience
Revuz et al.
Arch Dermatol 1987;123:1156-1158.
ABSTRACT
Toxic Epidermal Necrolysis: A Step Forward in Treatment
Heimbach et al.
JAMA 1987;257:2171-2175.
ABSTRACT
Management of Toxic Epidermal Necrolysis in a Pediatric Burn Center
Adzick et al.
Arch Pediatr Adolesc Med 1985;139:499-502.
ABSTRACT
|